Cargando…

Extracellular Matrix Remodeling in Chronic Liver Disease

PURPOSE OF THE REVIEW: This review aims to summarize the current knowledge of the extracellular matrix remodeling during hepatic fibrosis. We discuss the diverse interactions of the extracellular matrix with hepatic cells and the surrounding matrix in liver fibrosis, with the focus on the molecular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortiz, Cristina, Schierwagen, Robert, Schaefer, Liliana, Klein, Sabine, Trepat, Xavier, Trebicka, Jonel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Chronic Liver Disease (MF Lobato, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300084/ https://www.ncbi.nlm.nih.gov/pubmed/34337431 http://dx.doi.org/10.1007/s43152-021-00030-3

Ejemplares similares

Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats
por: Schierwagen, Robert, et al.
Publicado: (2013)

Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood
por: Decaris, Martin L., et al.
Publicado: (2016)

Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis
por: Lehmann, Jennifer, et al.
Publicado: (2019)

A New Treatment for Chronic Hepatitis B and D Offers Novel Insights Into Obesity and Hepatic Steatosis
por: Schierwagen, Robert, et al.
Publicado: (2020)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

Non-invasive assessment of liver fibrosis in autoimmune hepatitis: Diagnostic value of liver magnetic resonance parametric mapping including extracellular volume fraction
por: Mesropyan, Narine, et al.
Publicado: (2020)

Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease
por: Hall, Zoe, et al.
Publicado: (2017)

Long‐term prognostic value of the FibroTest in patients with non‐alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease
por: Munteanu, Mona, et al.
Publicado: (2018)

β-Arrestin2 is increased in liver fibrosis in humans and rodents
por: Schierwagen, Robert, et al.
Publicado: (2020)

Clinical Applications of Esophageal Impedance Monitoring and High-Resolution Manometry
por: Kessing, Boudewijn F., et al.
Publicado: (2012)

Influence of Obesity and Related Metabolic Alterations on Colorectal Cancer Risk
por: Aleksandrova, Krasimira, et al.
Publicado: (2012)

The mTOR Pathway and the Role of Energy Balance Throughout Life in Colorectal Cancer Etiology and Prognosis: Unravelling Mechanisms Through a Multidimensional Molecular Epidemiologic Approach
por: Weijenberg, Matty P., et al.
Publicado: (2013)

The Influence of Energetic Factors on Biomarkers of Postmenopausal Breast Cancer Risk
por: Neilson, Heather K., et al.
Publicado: (2013)

Impact of Diet, Body Mass Index, and Physical Activity on Cancer Survival
por: Kampman, Ellen, et al.
Publicado: (2012)

Does a Mediterranean-Type Diet Reduce Cancer Risk?
por: Schwingshackl, Lukas, et al.
Publicado: (2015)

The Role of the Microbiome in Cancer Initiation and Progression: How Microbes and Cancer Cells Utilize Excess Energy and Promote One Another’s Growth
por: Whisner, Corrie M., et al.
Publicado: (2019)

Folate and Its Impact on Cancer Risk
por: Pieroth, Renee, et al.
Publicado: (2018)

Carbohydrate Nutrition and the Risk of Cancer
por: Maino Vieytes, Christian A., et al.
Publicado: (2019)

The Rotterdam Study: objectives and design update
por: Hofman, Albert, et al.
Publicado: (2007)

The Rotterdam Study: 2010 objectives and design update
por: Hofman, Albert, et al.
Publicado: (2009)

Selective prevention of cardiometabolic diseases: activities and attitudes of general practitioners across Europe
por: de Waard, Anne-Karien M, et al.
Publicado: (2019)

Independent and combined associations of maternal and own smoking with adult lung function and COPD
por: Magnus, Maria C, et al.
Publicado: (2018)

Moderate alcohol consumption is associated with lower chronic disease burden expressed in disability-adjusted life years: a prospective cohort study
por: Beulens, Joline W. J., et al.
Publicado: (2017)

Osteoarthritis and risk of mortality in the USA: a population-based cohort study
por: Mendy, Angelico, et al.
Publicado: (2018)

Factors associated with adherence to guideline-recommended cardiovascular disease prevention among HIV clinicians
por: Galaviz, Karla I, et al.
Publicado: (2021)

Weight Change and the Onset of Cardiovascular Diseases: Emulating Trials Using Electronic Health Records
por: Katsoulis, Michail, et al.
Publicado: (2021)

Knowledge, perceptions and behaviours regarding dietary management of adults living with phenylketonuria
por: Firman, Sarah J., et al.
Publicado: (2022)

Pet ownership during the first 5 years after breast cancer diagnosis in the NEON-BC cohort
por: Lopes-Conceição, Luisa, et al.
Publicado: (2023)

Challenges in heart failure care in four European countries: a comparative study
por: Steiner, Bianca, et al.
Publicado: (2023)

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
por: Sauerbruch, Tilman, et al.
Publicado: (2023)

Sustainable Diets and Cancer: a Systematic Review
por: Karavasiloglou, Nena, et al.
Publicado: (2022)

Synthetic extracellular volume fraction without hematocrit sampling for hepatic applications
por: Mesropyan, Narine, et al.
Publicado: (2021)

PRO‐C3 and ADAPT algorithm accurately identify patients with advanced fibrosis due to alcohol‐related liver disease
por: Madsen, Bjørn S., et al.
Publicado: (2021)

Diet Satisfaction and Adequate Food Intake in Patients with Chronic Liver Diseases
por: Gerber, Suzannah, et al.
Publicado: (2022)

Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis
por: Torres, Sandra, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease
por: Cai, Xiaoyan, et al.
Publicado: (2021)

Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar‐associated protein 4
por: Madsen, Bjørn S., et al.
Publicado: (2020)

Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent
por: De Silva, Sampath, et al.
Publicado: (2018)

Network and satellite arrangements in liver disease
por: O'Grady, John G
Publicado: (2013)

Quantification of liver function using gadoxetic acid-enhanced MRI
por: Poetter-Lang, Sarah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1fc682avv7l8c3sal93kfe9d1j